Smith E, Rothschild AJ, Heo M, Peasley-Miklus C, Caswell M, Papademetriou E, Flint AJ, Mulsant BH, Meyers BS; STOP-PD Collaborative Study Group. Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. Int Clin Psychopharmacol. 2008;23(3):130-137....
Combination therapy of olanzapine (zyprexa) and fluoxetine (prozac) for treatment of bipolar disorder The invention provides methods and compositions for the treatment of Bipolar Disorder, Bipolar Depression or Unipolar Depression, all with or without psychotic features. This method employs a compound hav...
An Open Trial of Olanzapine in the Treatment of Patients with Psychotic Depression Compared to major depression without psychosis, psychotic depression often responds poorly to treatment with tricyclic antidepressants alone. Atypical anti... Erik,B.,Nelson,... - 《Annals of Clinical Psychiatry》 被引...
Olanzapine (Zyprexa, Zydis, Relprevv) is a drug used for treating patients with schizophrenia and manic episodes associated with bipolar I disorder and some types of depression. Learn about drug interactions, side effects, and pregnancy safety informatio
Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression. Biol Psychiatry 40: 253–258. Google Scholar Romeo E, Str A, Spalletta G, di Michele F, Hermann B, Holsboer F et al (1998). Effects of antidepressant treatment on neuroactive steroids in major ...
Conclusion: Olanzapine demonstrated superior efficacy compared with placebo in the short-term treatment of patients with bipolar I disorder with manic or mixed episodes, with or without psychotic features, and was generally well tolerated. According to preliminary data the antimanic efficacy of ...
Olanzapine, a new atypical antipsychotic drug, has been prescribed in the treatment of schizophrenia and psychotic mood disorders for approximately 2.3 million patients worldwide. Considering the increase in olanzapine prescriptions and the increased risk of suicide in this patient population, the number ...
Within the clinical picture, there were few dominant disorders present; anxiety, depression, low self-esteem, fear of feminization, with recurrent psychotic episodes. By the implementation of an intensive psychotherapeutic treatment, without the use of psychopharmacs, the weight was kept stable. In ...
The treatment resulted i... AT Hanretta,P Malek-Ahmadi - 《Journal of Ect》 被引量: 30发表: 2006年 Urinary Retention During Combined Treatment of Postpsychotic Depression With Duloxetine and Olanzapine Duloxetine, a dual-reuptake inhibitor of serotonin and norepinephrine, has been approved for ...
Olanzapine is an anti-psychotic drug that has been used for preventing and treating Chemotherapy-Induced Nausea and Vomiting (CINV). This study aimed to systematically review and meta-analyze the efficacy and safety of olanzapine for prophylaxis and treatment of CINV. Methods We conducted a systemati...